Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2225-2232

  Gundlach, Björn R ^a   Linhart, Heinz ^a,e   Dittmer, Ulf ^b   Sopper, Sieghart ^c   Reiprich, Stefan ^a   Fuchs, Dietmar ^d   Fleckenstein, Bernhard ^a   Hunsmann, Gerhard ^b   Stahl Hennig, Christiane ^b   Überla, Klaus ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Institut for Theoretische Physik Universitat of Innsbruck   (Austria)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; NEOPTERIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DELETION MUTANT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS CAPSID; VIRUS CULTURE; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0031041376     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2225-2232.1997     Document Type: Article

References (56)

1. Almond, N., K. Kent, M. Cranage, E. Rud, B. Clarke, and E. J. Stott. 1995. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344.
2. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fantl, C. Cheng Mayer, and B. M. Peterlin. 1994. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373-384.
3. Blatt, S. P., W. F. McCarthy, B. Bucko Krasnicka, G. P. Melcher, R. N. Boswell, J. Dolan, T. M. Freeman, J. M. Rusnak, R. E. Hensley, W. W. Ward, D. Barnes, and C. W. Hendrix. 1995. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J. Infect. Dis. 171:837-844.
4. Clark, A. G., M. Holodniy, D. H. Schwartz, D. A. Katzenstein, and T. C. Merigan. 1992. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration. J. Acquired Immune Defic. Syndr. 5:52-59.
5. Clerici, M., and G. M. Shearer. 1993. A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
6. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. C. Bernstein, D. L. Mann, G. M. Shearer, and J. A. Berzofsky. 1989. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 339:383-385.
7. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84:1892-1899.
8. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
9. Dittmer, U., W. Lüke, C. Stahl-Hennig, H. Petry, W. Bodemer, G. Hunsmann, and G. Voss. 1994. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. J. Med. Primatol. 23:21-26.
10. Dittmer, U., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, C. Stahl Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
11. Dolan, M. J., M. Clerici, S. P. Blatt, C. W. Hendrix, G. P. Melcher, R. N. Boswell, T. M. Freeman, W. Ward, R. Hensley, and G. M. Shearer. 1995. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 172: 79-87.
12. Du, Z., S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilyinskii, M. D. Daniel, J. U. Jung, and R. C. Desrosiers. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-674.
13. Fendrich, C., W. Lüke, C. Stahl-Hennig, O. Herchenröder, D. Fuchs, H. Wachter, and G. Hunsmann. 1989. Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIV-mac251). AIDS 3:305-307.
14. Flexner, C., A. Hügin, and B. Moss. 1987. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 330:259-262.
15. Fuchs, D., M. Banekovich, A. Hausen, J. Hutterer, G. Reibnegger, E. R. Werner, F. D. Gschnait, M. P. Dierich, and H. Wachter. 1988. Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1. Clin. Chem. 34:2415-2417.
16. Fuchs, D., A. Hausen, G. Reibnegger, E. R. Werner, M. P. Dierich, and H. Wachter. 1988. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 9:150-155.
17. Giavedoni, L. D., and T. Yilma. 1996. Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J. Virol. 70:2247-2251.
18. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
19. Giorgi, J. V., J. L. Fahey, D. C. Smith, L. E. Hultin, H. L. Cheng, R. T. Mitsuyasu, and R. Detels. 1987. Early effects of HIV on CD4 lymphocytes in vivo. J. Immunol. 138:3725-3730.
20. Hoch, J., S. M. Lang, M. Weeger, C. Stahl-Hennig, C. Coulibaly, U. Dittmer, G. Hunsmann, D. Fuchs, J. Müller, S. Sopper, B. Fleckenstein, and K. Überla. 1995. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:4807-4813.
21. Johnson, V., and R. E. Byington. 1990. Quantitative assays for virus infectivity, p. 71-76. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N. Y.
22. Kaluz, S., K. Kolble, and K. B. Reid. 1992. Directional cloning of PCR products using exonuclease III. Nucleic Acids Res. 20:4369-4370.
23. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
24. Kirchhoff, F., H. W. Kestler III, and R. C. Desrosiers. 1994. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J. Virol. 68:2031-2037.
25. Kneitz, C., T. Kerkau, J. Müller, C. Coulibaly, C. Stahl-Hennig, G. Hunsmann, T. Hünig, and A. Schimpl. 1993. Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet. Immunol. Immunopathol. 36:239-255.
26. Kovacs, J. A., M. Baseler, R. J. Dewar, S. Vogel, R. T. Davey, Jr., J. Falloon, M. A. Polis, R. E. Walker, R. Stevens, N. P. Salzman, J. A. Metcalf, H. Masur, and H. C. Lane. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N. Engl. J. Med. 332:567-575.
27. Kovacs, J. A., C. Bechtel, R. T. Davey, Jr., J. Falloon, M. A. Polis, R. E. Walker, J. A. Metcalf, V. Davey, S. C. Piscitelli, M. Baseler, R. Dewar, N. P. Salzman, H. Masur, and H. C. Lane. 1996. Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial. J. Infect. Dis. 173:840-848.
28. Lang, S. M., M. Weeger, C. Stahl-Hennig, C. Coulibaly, G. Hunsmann, J. Müller, H. Müller-Hermelink, D. Fuchs, H. Wachter, M. M. Daniel, R. C. Desrosiers, and B. Fleckenstein. 1993. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:902-912.
29. Leong, K. H., A. J. Ramsay, D. B. Boyle, and I. A. Ramshaw. 1994. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 68:8125-8130.
30. Lucey, D. R., S. A. McGuire, M. Clerici, K. Hall, J. Benton, C. A. Butzin, W. W. Ward, G. Shearer, R. N. Boswell, and C. W. Hendrix. 1991. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. J. Infect. Dis. 163:971-975.
31. Lucey, D. R., G. P. Melcher, C. W. Hendrix, R. A. Zajac, D. W. Goetz, C. A. Butzin, M. Clerici, R. D. Warner, S. Abbadessa, K. Hall, R. Jaso, B. Woolford, S. Miller, N. I. Stocks, C. M. Salinas, W. H. Wolfe, G. M. Shearer, and R. N. Boswell. 1991. Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. J. Infect. Dis. 164:631-637.
32. McDougal, J. S., A. Mawle, S. P. Cort, J. K. A. Nicholson, G. D. Cross, J. A. Scheppler-Campbell, D. Hicks, and J. Sligh. 1985. Role of T cell activation and expression of T4 antigen. J. Immunol. 135:3151-3162.
33. Miedema, F., A. J. Petit, F. G. Terpstra, J. K. Schattenkerk, F. de Wolf, B. J. Al, M. Roos, J. M. Lange, S. A. Danner, J. Goudsmit, et al. 1988. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Gin. Invest. 82:1908-1914.
34. Morphey-Corb, M., L. N. Martin, B. Davison-Fairburn, R. C. Montelaro, M. Miller, M. West, S. Ohkawa, G. Baskin, J. Zhang, S. D. Putney, A. C. Allison, and D. A. Eppstein. 1989. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293-1297.
35. Murray, H. W., K. E. Squires, E. Gassyuk Bolev, and J. K. DePamphilis. 1992. Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation. Am. J. Med. 93:234.
36. Norley, S., B. Beer, D. Binninger-Schinzel, C. Cosma, and R. Kurth. 1996. Protection from pathogenic SIVmac challenge following short-term infection with a Nef-deficient attenuated virus. Virology 219:195-205.
37. Potts, B. J. 1990. Mini reverse transcriptase (RT) assay, p. 103-106. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N. Y.
38. Ramsay, A. J., K. H. Leong, D. Boyle, J. Ruby, and I. A. Ramshaw. 1994. Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod. Fertil. Dev. 6:389-392.
39. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14: 155-157.
40. Ramshaw, I. A., M. E. Andrew, S. M. Phillips, D. B. Boyle, and B. E. H. Coupar. 1987. Recovery of immunodeficient mice from a vaccinia virus/IL2 recombinant infection. Nature 329:545-546.
41. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
42. Sawyer, L. A., J. A. Metcalf, K. C. Zoon, E. J. Boone, J. A. Kovacs, H. C. Lane, and G. V. Quinnan. 1990. Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose. Cytokine 2:247-252.
43. Schnittman, S. M., S. Vogel, M. Baseler, H. C. Lane, and R. T. Davey. 1994. A phase I study of interferon-alpha 2b in combination with interleukin-2 in patients with human immunodeficiency virus infection. J. Infect. Dis. 169: 981-989.
44. Schwartz, D. H., G. Skowron, and T. C. Merigan. 1991. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 4:11-23.
45. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
46. Stahl-Hennig, C., O. Herchenröder, S. Nick, M. Evers, M. Stille-Siegener, K. D. Jentsch, F. Kirchhoff, T. Tolle, T. J. Gatesman, W. Lüke, and G. Hunsmann. 1990. Experimental infection of macaques with HIV-2ben, a novel HIV-2 isolate. AIDS 4:611-617.
47. Stahl-Hennig, C., G. Voss, S. Nick, H. Petry, D. Fuchs, H. Wachter, C. Coulibaly, W. Lüke, and G. Hunsmann. 1992. Immunization with tweenether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SW infection. Virology 186:588-596.
48. Teppler, H., G. Kaplan, K. Smith, P. Cameron, A. Montana, P. Meyn, and Z. Cohn. 1993. Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 167:291-298.
49. Teppler, H., G. Kaplan, K. A. Smith, A. L. Montana, P. Meyn, and Z. A. Cohn. 1993. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177:483-492.
50. Trono, D. 1995. HIV accessory proteins: leading roles for the supporting cast. Cell 82:189-192.
51. Überla, K., C. Stahl Hennig, D. Böttiger, K. Mätz-Rensing, F. J. Kaup, J. Li, W. A. Haseltine, B. Fleckenstein, G. Hunsmann, B. Oberg, and J. Sodroski. 1995. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA 92:8210-8214.
52. Voss, G., U. Dittmer, S. Nick, C. Stahl-Hennig, C. Coulibaly, H. Petry, W. Lücke, and G. Hunsmann. 1993. Induction of T-cell proliferation in rhesus monkeys immunized with tween-ether-treated SIVmac and loss of proliferative activity after virus infection, p. 89-94. In P. Racz, N. L. Letvin, and J. C. Gluckman (ed.), Animal models of HIV infection. Karger, Basel, Switzerland.
53. Voss, G., S. Nick, C. Stahl-Hennig, C. Coulibaly, H. Petry, W. Lüke, and G. Hunsmann. 1992. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques. J. Gen. Virol. 73:2273-2281.
54. Wood, R., J. G. Montoya, S. K. Kundu, D. H. Schwartz, and T. C. Merigan. 1993. Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study. J. Infect. Dis. 167:519-525.
55. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
56. Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Feldman, P. S. Sarin, and R. C. Gallo. 1986. Long-term cultures of HTLV-III infected T cells: a model of cytopathology of T cell depletion in AIDS. Science 231:850-853.